New Enterprise Associates 14, L.P. filings

This page lists the SEC filings reported by New Enterprise Associates 14, L.P..

SEC filings by New Enterprise Associates 14, L.P. (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-05-10New Enterprise Associates 14, L.P.NEXTNAV INC.8,189,1566.8%EDGAR
SC 13D/A2024-05-06New Enterprise Associates 14, L.P.CHAMPIONS ONCOLOGY, INC.1,713,72012.6%EDGAR
SC 13D/A2024-04-02New Enterprise Associates 14, L.P.Adaptimmune Therapeutics PLC102,478,6726.7%EDGAR
SC 13D/A2023-10-13New Enterprise Associates 14, L.P.SYNLOGIC, INC.2,922,77434.4%EDGAR
SC 13D/A2023-03-30New Enterprise Associates 14, L.P.Adaptimmune Therapeutics PLC102,478,67210.3%EDGAR
SC 13G/A2023-02-03New Enterprise Associates 14, L.P.Tuya Inc.119,019,27323.8%EDGAR
SC 13D/A2023-01-09New Enterprise Associates 14, L.P.Oyster Point Pharma, Inc.--EDGAR
SC 13D/A2022-11-21New Enterprise Associates 14, L.P.Oyster Point Pharma, Inc.5,925,28722.1%EDGAR
SC 13D2022-08-12New Enterprise Associates 14, L.P.ZeroFox Holdings, Inc.18,068,51315.3%EDGAR
SC 13D/A2022-05-24New Enterprise Associates 14, L.P.IMARA Inc.--EDGAR
SC 13D/A2022-04-25New Enterprise Associates 14, L.P.IMARA Inc.1,920,8497.3%EDGAR
SC 13G2022-02-15New Enterprise Associates 14, L.P.Tuya Inc.123,284,63329.5%EDGAR
SC 13D/A2022-01-10New Enterprise Associates 14, L.P.IMARA Inc.3,695,19214.1%EDGAR
SC 13D/A2022-01-05New Enterprise Associates 14, L.P.LUMOS PHARMA, INC.--EDGAR
SC 13D2021-12-01New Enterprise Associates 14, L.P.NEXTNAV INC.8,189,1568.6%EDGAR
SC 13D/A2021-11-22New Enterprise Associates 14, L.P.Casper Sleep Inc.6,222,50215.0%EDGAR
SC 13D/A2021-03-11New Enterprise Associates 14, L.P.Tracon Pharmaceuticals, Inc.--EDGAR
SC 13G/A2021-02-12New Enterprise Associates 14, L.P.Surface Oncology, Inc.--EDGAR
SC 13D/A2020-12-10New Enterprise Associates 14, L.P.Mersana Therapeutics, Inc.--EDGAR
SC 13D/A2020-11-19New Enterprise Associates 14, L.P.Mersana Therapeutics, Inc.3,959,5205.8%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.